ArticleNutrition journal2025
Association between sulfur microbial diet and the risk of dementia: a large-scale prospective cohort study.
Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Higher consumption of sulfur microbial diet is associated with the increased risk of chronic kidney disease.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe sulfur microbial diet (SMD), a dietary pattern linked to sulfur-metabolizing gut bacteria, has been associated with metabolic disorders. However, its role in dementia risk remains unclear.
methodsThis prospective cohort study investigated the association between SMD and dementia risk and examined potential mechanisms. We included 125,714 UK Biobank participants who completed at least two 24-hour dietary recalls. SMD scores were calculated based on food intake associated with sulfur-metabolizing bacteria. The primary outcome was incident dementia, including Alzheimer’s disease (AD), vascular dementia (VD), and frontotemporal dementia (FTD). Secondary outcomes included cognitive function and brain volume changes. Cox proportional hazards models were employed to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Stratified and mediation analyses were conducted to explore potential population heterogeneity and mechanisms.
resultsOver a median follow-up of 8.58 years, 691 dementia cases occurred. A U-shaped association was observed between SMD scores and the risk of dementia and AD. Compared with the middle quintile, participants in the highest quintile had a 37% higher dementia risk (HR = 1.37, 95% CI: 1.08–1.74) and a 46% higher AD risk (HR = 1.46, 95% CI: 1.00–2.14). No significant association was found for the lowest quintile. Associations were stronger in males and older adults. Diabetes mediated 8% of the total effect of high SMD adherence on dementia risk. No significant associations were observed for VD and FTD. Cognitive function changes were not notable. Higher SMD adherence was linked to reduced thalamic grey matter volume, while lower adherence was associated with increased volume in the precentral and postcentral gyri.
conclusionsA U-shaped relationship exists between SMD and dementia risk, particularly AD, with potential sex- and age-specific differences. Diabetes may partly mediate this association. SMD may also affect brain volume. These findings suggest a possible role of SMD in the diet-microbiota-gut-brain axis and neurodegeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.